Vaccinate

Getting vaccinated is the best thing you can do as an individual to help safeguard yourself and your community against COVID-19.

Vaccine FAQs

Host a School-Based Vaccination Event

Preguntas Frecuentes Sobre La Vacunación

Which COVID-19 vaccines are available and who is eligible?

Three vaccines have been approved under the Food and Drug Administration’s (FDA) Emergency Use Authorization (EUA).  

Pfizer-Biontech

Who: People 5 years and older

Doses: 2 doses given 3 weeks (21 days) apart

When: Fully vaccinated 2 weeks after second dose

Moderna

Who: People 18 years and older

Doses: 2 doses given 4 weeks (28 days) apart

When: Fully vaccinated 2 weeks after second dose

Johnson & Johnson’s Janssen

Who: People 18 years and older

Doses: 1 dose

When: Fully vaccinated 2 weeks after dose

*The CDC recommends that everyone 12 years old and above receive a third dose of mRNA vaccine (Pfizer or Moderna booster) and recipients of the one-dose J&J vaccine receive a second dose, preferably of an mRNA vaccine.

Vaccine and Booster Eligibility by Age 

Ages 4 and under
  • This age group is not yet eligible for any vaccine or booster.
  • EUA approval for the Pfizer-BioNTech vaccine for children 6 months old to 4 months old may be available by spring 2022
  • Children between the ages of 2 and 4 should continue to wear a mask in public settings.
Ages 5 to 11
  • This age group is eligible to receive the Pfizer-BioNTech COVID-19 vaccine.
  • The Pfizer vaccine for children ages 5 to 11 is administered as a two-dose primary series, 3 weeks apart. It is a lower dose (10 micrograms) compared to the Pfizer vaccine given to people 12 and older (which is 30 micrograms).
  • The CDC recommends that people ages 5 and older who are moderately or severely immunocompromised receive an additional primary shot (third dose) of an mRNA vaccine 28 days after receiving their second dose.
  • Children 5 through 11 who are fully vaccinated and are not immunosuppressed are not authorized for a booster at this time.
  • Children 5 through 11 years old will receive a separate vaccine formulation denoted with an orange cap of the Pfizer-BioNTech COVID-19 Vaccine, and will receive the vaccine with a smaller needle.
Ages 12 to 17
  • This age group can receive the Pfizer-BioNTech adult COVID-19 vaccine series (30 mcg dose).
  • Adolescents 12 through 17 who have certain medical conditions associated with immunosuppression can receive an additional primary dose at least 28 days after their second dose.
  • All adolescents can receive a Pfizer-BioNTech booster five months after their second dose.
  • At this time, only the Pfizer-BioNTech COVID-19 vaccine is authorized and recommended for adolescents 12 through 17.
Ages 18 and up
  • All adults 18 and older are eligible for all approved vaccines. Both the Pfizer-BioNTech and Moderna vaccines have received full approval from the FDA.
  • All adults 18 and older are eligible for a booster 5 months after their second dose of an mRNA vaccine (Pfizer, Moderna) or after their first and only dose of the J&J vaccine.
  • The CDC recommends that everyone 12 years old and above receive a third dose of mRNA vaccine (Pfizer or Moderna booster) and recipients of the one-dose J&J vaccine receive a second dose, preferably of an mRNA vaccine.
  • Vaccines are the best protection against severe illness caused by omicron and other variants. Boosters increase protection against infection from all known variants, including omicron, and greatly decrease the likelihood of severe disease if infected.

Why host a vaccination event?

 

Reduce transmission of COVID-19 in schools

and the community

 

Minimize lost learning days

Offer vaccinations to students and

families from a trusted

community institution

 

Help level the playing field for

vaccine access

 

Drive vaccine uptake in the

wider community